ALLERGIC CONJUNCTIVITIS
Clinical trials for ALLERGIC CONJUNCTIVITIS explained in plain language.
Never miss a new study
Get alerted when new ALLERGIC CONJUNCTIVITIS trials appear
Sign up with your email to follow new studies for ALLERGIC CONJUNCTIVITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody shots aim to stop itchy eyes from birch pollen
Symptom relief Recruiting nowThis study tests two experimental drugs (REGN5713 and REGN5715) given alone or together to reduce eye allergy symptoms caused by birch pollen. About 350 adults with birch pollen allergy will receive the drugs or a placebo and then be exposed to pollen in a controlled setting to m…
Matched conditions: ALLERGIC CONJUNCTIVITIS
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC
-
New eye drops aim to stop allergy itch and redness
Symptom relief Recruiting nowThis study tests an experimental eye drop called TL-925 for seasonal allergic conjunctivitis (eye allergies). About 60 adults with a history of eye allergies will receive either the active drop or a placebo. The goal is to see if TL-925 reduces eye itching and redness after expos…
Matched conditions: ALLERGIC CONJUNCTIVITIS
Phase: PHASE2 • Sponsor: Telios Pharma, Inc. • Aim: Symptom relief
Last updated May 11, 2026 20:50 UTC
-
Scientists decode tear fingerprints to better understand eye diseases
Knowledge-focused Recruiting nowThis study collects and analyzes tears from 300 people with healthy eyes or with dry eye, infectious keratitis, mucous membrane pemphigoid, or allergic conjunctivitis. The goal is to create a unique protein and metabolite fingerprint for each condition. No treatment is given; the…
Matched conditions: ALLERGIC CONJUNCTIVITIS
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC